Liquid biopsy·AI·3D printing lift Korea’s platform tech trio[K-bio Pulse] 김승권 2025.12.26 오전 08:00 YooSeok Hong, CEO Genome&Company “Enhancing the Value of GENA-104 for Sub-licensing” 김진수 2025.02.27 오전 10:22 Vigencell Soars on Trial Win; Foreign Buying Lifts Nextbiomedical [K-Bio Pulse] 석지헌 2025.11.28 오전 09:18 로딩중..
Sub-licensing
Sub-licensing
![Liquid biopsy·AI·3D printing lift Korea’s platform tech trio[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/12/PS25122600103b.jpg)
![Vigencell Soars on Trial Win; Foreign Buying Lifts Nextbiomedical [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/11/PS25112800280b.jpg)